Fund Holdings — Atlas Venture Life Science Advisors, LLC

Total Portfolio Value:
$631.19M
Total Bought:
$61.89M
Total Sold:
$120.75M
Net Transaction:
-$58.87M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Kymera Therapeutics, Inc.(KYMR)2,847,5412,847,5410$326.53M$318.33M50.43%-$8.20M
Disc Medicine, Inc.(IRON)1,513,8751,384,025-129,850$110.72M$90.60M14.35%-$20.13M
Obsidian Therapeutics, Inc.04,503,149+4,503,149$0$61.83M9.80%+$61.83M
Kailera Therapeutics, Inc.5,171,2825,171,2820$113.92M$59.06M9.36%-$54.87M
Dyne Therapeutics, Inc.(DYN)6,800,0993,440,720-3,359,379$151.03M$55.43M8.78%-$95.60M
Q32 Bio, Inc.2,717,1062,717,1060$34.62M$22.47M3.56%-$12.15M
Sionna Therapeutics, Inc.2,995,6022,995,6020$131.78M$15.76M2.50%-$116.02M
Korro Bio, Inc.962,884773,260-189,624$12.69M$7.66M1.21%-$5.03M
Odyssey Therapeutics, Inc.02,692+2,692$0$59.8K0.01%+$59.8K
Page 1 of 1
Atlas Venture Life Science Advisors, LLC — 13F Holdings — Q3 2026 | TickerTrail